2013 - CTS 2013 Congress

This page contains exclusive content for the member of the following sections: TTS, CTS

Plenary: Metabolic Nutrition and Regenerative Medicine

18.2 - Metabolic Effects of Immunosuppressive Agents

Presenter: Livio, Luzi, Milan, Italy
Authors: Livio Luzi

Cellular and organ transplantation have the highest rate of success when autologous or from a twin living donor with the notable exception of transplanting cells/organs in presence of autoimmunity. Autoimmunity recurrence make it always necessary the utilization of immunosuppressive agents. Endocrine organs are particularly susceptible to elicit antigens evoking auto-antibodies. Type 1 diabetes, Hashimoto thyroditis, Addison disease, celiac disease are all characterized by organ-specific autoimmunity.

Most immunosuppressive drugs have potent metabolic effects aside the immune-modulation effect. Therefore in endocrine diseases, the action of immunosuppressive drugs must be carefully balanced to avoid negative effects on the graft and the whole recipient as the development of de novo diabetes. The metabolic effects of immunosuppressive drugs will be presently reviewed systematically highlighting metabolic methodology required for correct assessment and follow up of the metabolic outcome of the graft.

Genetic and epigenetic factors of donor and recipient which may determine the final outcome of the graft will be reviewed. The panel of drugs and food integrators available to counteract metabolic effects of immune-suppression will be also reviewed.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory
This email address is being protected from spambots. You need JavaScript enabled to view it.


The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7